Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan versus valsartan in chronic heart failure with chronic kidney disease
ChiCTR1900028468Phase 4Recruiting
- Sponsor
- Tianjin First Central Hospital
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sacubitril + valsartan and valsartan in heart failure (HF) and chronic kidney disease (CKD) (2 arms), sponsored by Tianjin First Central Hospital. Primary endpoints: blood pressure, resting heart rate and 4 more. Started Feb 2020; status: recruiting.
02
Drugs
sacubitril + valsartanvalsartan
03
Conditions
heart failure (HF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR1900028468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028468.